US clears new treatment option for Dravet syndrome by Selina McKee | Aug 24, 2018 | News | 0 US regulators have approved Biocodex’ Diacomit for the treatment of seizures associated with Dravet syndrome (DS), a rare and difficult to treat form of epilepsy. Read More
Martindale’s oral epilepsy drug bags EU nods by Selina McKee | Oct 25, 2016 | News | 0 UK-based Martindale Pharma has announced regulatory clearance of an oral formulation of its epilepsy therapy clobazam in Europe. Read More